Xenome: Immersed in venom

Xenome Ltd., one of several spin-offs from research begun by the University of Queensland, aims to take advantage of the great variety of venomous species populating Australia by evaluating the poisons as potential therapeutics. The company is building libraries of the DNA sequences encoding venom peptides and plans to use the peptides as drug candidates against a variety of targets.

Roger Drinkwater, one of Xenome's three research directors, said most venom researchers have concentrated on a few specific venom peptides in each species.

Read the full 821 word article

How to gain access

Continue reading with a
two-week free trial.